Cangrelor intermediate 10596-22-2
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- China
- Brand name
- Bocimed
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- api, pharmaceutical, pharmaceutical intermediate, cangrelor
- Category
- Organic Intermediate
Shanghai Bocimed Pharmaceutical Co., Ltd.
China
- Verified Certificate
-
7
| Product name | Cangrelor intermediate 10596-22-2 | Certification | - |
|---|---|---|---|
| Category | Organic Intermediate | Ingredients | - |
| Keyword | api , pharmaceutical , pharmaceutical intermediate , cangrelor | Unit Size | - |
| Brand name | Bocimed | Unit Weigh | - |
| origin | China | Stock | - |
| Supply type | - | HS code | - |
Product Information
We manufacture and provide Cangrelor intermediate with commercial capability
CAS 10596-22-2
Purity is ≥ 98%
Cangrelor:
The binding of cangrelor to the P2Y12 receptor inhibits platelet activation as well as aggregation when mediated in whole or in part via this receptor. Cangrelor can be derived completely from synthetic materials, and is an analogue of adenosine triphosphate (ATP).
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Ms. Ying
- Address
- Building 9, No. 150, Cailun Road, Zhangjiang High-Tech Park, Shanghai, China
- Product Category
- Organic Intermediate
- Year Established
- 2013
- No. of Total Employees
- 51-100
- Company introduction
-
Shanghai Bocimed Pharmaceutical Co., Ltd. is a high-tech enterprise specialized in drug research and development technical services, one of Shanghai high-tech enterprises, Shanghai integrity created enterprise, Shanghai SME innovation enterprises. The company started in 2007, formerly known as Shanghai MABCT Medicine Technology Co., Ltd., registered in Jinshan Petrochemical Zone, mainly engaged in sales of raw materials, the drug import registration and China regional cooperation development.
Bocimed is focus on the R&D and manufacture of pharmaceutical API and intermediates, has the R&D center in Shanghai with more than 2500m2, and the factory is located in Gansu Province, China.
- Main Product
Related Products
Carbimazole, CAS NO.: 22232-54-8
Methomyl
120/80 SYMBIOSAL _ antihypertensive salt
3,4-Dimethoxybenzoic acid (CAS 93-07-2)
3-chloro-4-fluroaniline (CAS 367-21-5)
